APP
MIRA icon

Avantax Planning Partners’s MIRA Pharmaceuticals MIRA Stock Holding History

Avantax Planning Partners’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-32,000
Closed -$41.6K – 448
2024
Q3 		$41.6K Sell
32,000
-86,751
-73% -$138K ﹤0.01% 435
2024
Q2 		$75.6K Buy
+118,751
New +$97.6K ﹤0.01% 456

Other funds holding MIRA

CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Avantax Planning Partners's MIRA Position: Q4 2024 in Review

Avantax Planning Partners sold out of MIRA Pharmaceuticals (MIRA) in Q4 2024, closing a stake of 32,000 shares — an estimated $41.6K sold.

Avantax Planning Partners first reported a position in MIRA in Q2 2024 and held it in 2 quarters. The position peaked at $75.6K in Q2 2024. 24 funds tracked by Wall St. Rank hold MIRA as of Q4 2024.

  • Avantax Planning Partners reported no remaining MIRA Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Avantax Planning Partners sold 32,000 MIRA Pharmaceuticals shares in Q4 2024, an estimated $41.6K.
  • Avantax Planning Partners first reported a position in MIRA Pharmaceuticals in Q2 2024 and held it in 2 quarters.
  • Avantax Planning Partners's MIRA Pharmaceuticals position peaked at $75.6K in Q2 2024.
  • 24 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q4 2024.

Based on Avantax Planning Partners's 13F filing for Q4 2024, filed 7 Feb 2025.